Cargando…

Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study

BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles. METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Chunyue, Cao, Han, Shan, Guangliang, Zhao, Wei, Zhang, Han, Niu, Kaijun, Cui, Ze, Tang, Naijun, Liu, Kuo, Pan, Li, Han, Xiaoyan, Wang, Zhengfang, Meng, Ge, Sun, Jixin, Shan, Anqi, Yan, Yuxiang, He, Huijing, Xu, Zhiyuan, Cao, Yajing, Peng, Wenjuan, Sun, Yanyan, Xie, Yunyi, Liu, Xiaohui, Li, Bingxiao, Wen, Fuyuan, Zhang, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859748/
https://www.ncbi.nlm.nih.gov/pubmed/33553319
http://dx.doi.org/10.21037/atm-20-3899
_version_ 1783646802567757824
author Guo, Chunyue
Cao, Han
Shan, Guangliang
Zhao, Wei
Zhang, Han
Niu, Kaijun
Cui, Ze
Tang, Naijun
Liu, Kuo
Pan, Li
Han, Xiaoyan
Wang, Zhengfang
Meng, Ge
Sun, Jixin
Shan, Anqi
Yan, Yuxiang
He, Huijing
Xu, Zhiyuan
Cao, Yajing
Peng, Wenjuan
Sun, Yanyan
Xie, Yunyi
Liu, Xiaohui
Li, Bingxiao
Wen, Fuyuan
Zhang, Ling
author_facet Guo, Chunyue
Cao, Han
Shan, Guangliang
Zhao, Wei
Zhang, Han
Niu, Kaijun
Cui, Ze
Tang, Naijun
Liu, Kuo
Pan, Li
Han, Xiaoyan
Wang, Zhengfang
Meng, Ge
Sun, Jixin
Shan, Anqi
Yan, Yuxiang
He, Huijing
Xu, Zhiyuan
Cao, Yajing
Peng, Wenjuan
Sun, Yanyan
Xie, Yunyi
Liu, Xiaohui
Li, Bingxiao
Wen, Fuyuan
Zhang, Ling
author_sort Guo, Chunyue
collection PubMed
description BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles. METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei (CHCN-BTH) using a stratified, multistage cluster sampling method. Data were collected through questionnaire surveys, anthropometric measures and laboratory tests. Restricted cubic spline (RCS) functions, multivariate logistic regression, sensitivity analyses and stratified analyses were used to evaluate the association between Lp(a) and CHD. RESULTS: A total of 25,343 participants were included, with 1,364 (5.38%) identified as having CHD. Elevated Lp(a) levels were linearly related to an increased risk of CHD (P(overall-association)<0.0001 and P(nonlinear-association)=0.8468). Multivariate logistic regression analysis indicated that subjects with Lp(a) ≥300 mg/L had a higher risk of CHD [OR (95% CI): 1.36 (1.17, 1.57)] than did individuals with Lp(a) <300 mg/L. Compared with individuals with Lp(a) <119.0 mg/L (<50th percentile), the ORs (95% CI) for CHD in the 51st–80th, 81st–95th and >95th percentiles were 1.07 (0.93, 1.23), 1.26 (1.07, 1.50) and 1.68 (1.30, 2.17), respectively (P for trend <0.0001). This association was also found among the subgroup of subjects without dyslipidemia, including those with normal total cholesterol (TC) (<6.2 mmol/L), triglycerides (TG) (<2.3 mmol/L), high-density lipoprotein cholesterol (HDL-C) (≥1.0 mmol/L) and low-density lipoprotein cholesterol (LDL-C) (<4.1 mmol/L). Elevated Lp(a) and dyslipidemia significantly contributed to a higher risk of CHD with synergistic effects. Stratified analyses showed that elevated Lp(a) concentrations were significantly associated with an increased risk of CHD in the subgroups of individuals who were noncurrent drinkers, overweight individuals, individuals with hypertension, individuals who engaged in moderate physical activity, those without diabetes mellitus and individuals in Beijing and Tianjin. CONCLUSIONS: Elevated Lp(a) concentrations were linearly associated with a higher risk of CHD in the general Chinese community population, especially in normolipidemic subjects. Both dyslipidemia and elevated Lp(a) independently or synergistically contributed to the risk of CHD. Our results suggest that more attention should be paid to the levels of Lp(a) in normolipidemic subjects, which may be an early predictor of CHD.
format Online
Article
Text
id pubmed-7859748
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78597482021-02-05 Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study Guo, Chunyue Cao, Han Shan, Guangliang Zhao, Wei Zhang, Han Niu, Kaijun Cui, Ze Tang, Naijun Liu, Kuo Pan, Li Han, Xiaoyan Wang, Zhengfang Meng, Ge Sun, Jixin Shan, Anqi Yan, Yuxiang He, Huijing Xu, Zhiyuan Cao, Yajing Peng, Wenjuan Sun, Yanyan Xie, Yunyi Liu, Xiaohui Li, Bingxiao Wen, Fuyuan Zhang, Ling Ann Transl Med Original Article BACKGROUND: To evaluate the contributions of elevated lipoprotein(a) [Lp(a)] to the risk of coronary heart disease (CHD) in the general Chinese community population according to different lipid profiles. METHODS: We recruited individuals aged over 18 years from the baseline survey of the Cohort Study on Chronic Disease of Communities Natural Population in Beijing, Tianjin and Hebei (CHCN-BTH) using a stratified, multistage cluster sampling method. Data were collected through questionnaire surveys, anthropometric measures and laboratory tests. Restricted cubic spline (RCS) functions, multivariate logistic regression, sensitivity analyses and stratified analyses were used to evaluate the association between Lp(a) and CHD. RESULTS: A total of 25,343 participants were included, with 1,364 (5.38%) identified as having CHD. Elevated Lp(a) levels were linearly related to an increased risk of CHD (P(overall-association)<0.0001 and P(nonlinear-association)=0.8468). Multivariate logistic regression analysis indicated that subjects with Lp(a) ≥300 mg/L had a higher risk of CHD [OR (95% CI): 1.36 (1.17, 1.57)] than did individuals with Lp(a) <300 mg/L. Compared with individuals with Lp(a) <119.0 mg/L (<50th percentile), the ORs (95% CI) for CHD in the 51st–80th, 81st–95th and >95th percentiles were 1.07 (0.93, 1.23), 1.26 (1.07, 1.50) and 1.68 (1.30, 2.17), respectively (P for trend <0.0001). This association was also found among the subgroup of subjects without dyslipidemia, including those with normal total cholesterol (TC) (<6.2 mmol/L), triglycerides (TG) (<2.3 mmol/L), high-density lipoprotein cholesterol (HDL-C) (≥1.0 mmol/L) and low-density lipoprotein cholesterol (LDL-C) (<4.1 mmol/L). Elevated Lp(a) and dyslipidemia significantly contributed to a higher risk of CHD with synergistic effects. Stratified analyses showed that elevated Lp(a) concentrations were significantly associated with an increased risk of CHD in the subgroups of individuals who were noncurrent drinkers, overweight individuals, individuals with hypertension, individuals who engaged in moderate physical activity, those without diabetes mellitus and individuals in Beijing and Tianjin. CONCLUSIONS: Elevated Lp(a) concentrations were linearly associated with a higher risk of CHD in the general Chinese community population, especially in normolipidemic subjects. Both dyslipidemia and elevated Lp(a) independently or synergistically contributed to the risk of CHD. Our results suggest that more attention should be paid to the levels of Lp(a) in normolipidemic subjects, which may be an early predictor of CHD. AME Publishing Company 2021-01 /pmc/articles/PMC7859748/ /pubmed/33553319 http://dx.doi.org/10.21037/atm-20-3899 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Guo, Chunyue
Cao, Han
Shan, Guangliang
Zhao, Wei
Zhang, Han
Niu, Kaijun
Cui, Ze
Tang, Naijun
Liu, Kuo
Pan, Li
Han, Xiaoyan
Wang, Zhengfang
Meng, Ge
Sun, Jixin
Shan, Anqi
Yan, Yuxiang
He, Huijing
Xu, Zhiyuan
Cao, Yajing
Peng, Wenjuan
Sun, Yanyan
Xie, Yunyi
Liu, Xiaohui
Li, Bingxiao
Wen, Fuyuan
Zhang, Ling
Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
title Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
title_full Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
title_fullStr Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
title_full_unstemmed Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
title_short Elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general Chinese community population: the CHCN-BTH study
title_sort elevated lipoprotein(a) and risk of coronary heart disease according to different lipid profiles in the general chinese community population: the chcn-bth study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859748/
https://www.ncbi.nlm.nih.gov/pubmed/33553319
http://dx.doi.org/10.21037/atm-20-3899
work_keys_str_mv AT guochunyue elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT caohan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT shanguangliang elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT zhaowei elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT zhanghan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT niukaijun elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT cuize elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT tangnaijun elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT liukuo elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT panli elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT hanxiaoyan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT wangzhengfang elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT mengge elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT sunjixin elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT shananqi elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT yanyuxiang elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT hehuijing elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT xuzhiyuan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT caoyajing elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT pengwenjuan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT sunyanyan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT xieyunyi elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT liuxiaohui elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT libingxiao elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT wenfuyuan elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy
AT zhangling elevatedlipoproteinaandriskofcoronaryheartdiseaseaccordingtodifferentlipidprofilesinthegeneralchinesecommunitypopulationthechcnbthstudy